NCT00434135View on ClinicalTrials.gov

Alimta and Gemcitabine in Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2008

Conditions
Non-Small Cell Lung CancerStage IIIB or IV
Interventions
DRUG

gemcitabine plus pemetrexed, paclitaxel plus gemcitabine

gemcitabine 1,250 mg/sqm days 1\&8 + pemetrexed 500 mg/sqm day 8 paclitaxel 120 mg/sqm + gemcitabine 1,000 mg/sqm days 1\&8

Trial Locations (1)

80131

National Tumor Institute, Naples

All Listed Sponsors
lead

Southern Italy Cooperative Oncology Group

OTHER

NCT00434135 - Alimta and Gemcitabine in Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter